Status:
UNKNOWN
Telemedicine-based Model of Care for the Management of Hepatitis C Infected Patients
Lead Sponsor:
University of La Laguna
Conditions:
Hepatitis C
Telemedicine
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To achieve World Health Organization 2030 goals of hepatitis C elimination it is mandatory to document after treatment sustained virological response (SVR). Currently, patients after completing treatm...
Detailed Description
This is a prospective, randomized study in which hepatitis C (VHC) infected patients will be randomized to two strategies for HCV care. All HCV infected patients will be evaluated in a first face-to-...
Eligibility Criteria
Inclusion
- 18 years or older
- have contact telephone number
- sing the informed consent
Exclusion
- have advanced fibrosis (F3) or cirrhosis (F4)
- are under surveillance by another specialist or drug addition center.
Key Trial Info
Start Date :
May 25 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
136 Patients enrolled
Trial Details
Trial ID
NCT04411381
Start Date
May 25 2020
End Date
December 1 2023
Last Update
May 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Universitario de Canarias
San Cristóbal de La Laguna, Santa CRUZ DE Tenerife, Spain, 38320